CMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Compass Minerals International Inc (CMP) is not a good buy right now for a Beginner investor focused on long-term investing with $50,000-$100,000 to deploy. The stock has some short-term technical strength and supportive hedge fund activity, but the latest quarter showed weaker revenue, sharply lower net income and EPS, and the analyst stance remains bearish with an Underweight rating. Given the lack of a strong Intellectia buy signal and the mixed fundamental picture, I would not call this a direct buy today.
CMP is in a short-term bullish technical phase: MACD histogram is positive and expanding, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). However, RSI_6 is around 72.1, which suggests the stock is stretched near overbought levels rather than offering a clean entry. Price closed at 28.00 versus a previous close of 28.24, and the key resistance area is close at R1 28.382 with R2 at 29.662. That means the stock is near resistance after a strong recent move, so upside exists but the current level is not an ideal long-term entry for an impatient beginner.
["Hedge funds are buying aggressively, with buying amount up 302.06% over the last quarter.", "Technical trend is positive: MACD is above zero and rising, and moving averages are bullishly aligned.", "Options sentiment is strongly bullish with very low put-call ratios.", "Gross margin improved to 18.31% in the latest quarter, showing some operational efficiency progress."]
["Latest quarter revenue fell 8.37% year over year to $453.2 million.", "Net income dropped 139.69% year over year and EPS fell 138.96%, indicating sharply weaker profitability.", "JPMorgan kept an Underweight rating and only raised the target to $20, still well below the current price.", "RSI is near overbought territory, and price is sitting close to resistance.", "Insider trading trends are neutral and there is no recent congress trading data."]
In Q2 2026, Compass Minerals reported revenue of $453.2 million, down 8.37% year over year. Net income fell to $12.7 million, down 139.69% YoY, and EPS declined to $0.30, down 138.96% YoY. The only bright spot was gross margin, which improved to 18.31% from the prior year, suggesting better operating efficiency even though the top line and bottom line weakened.
Recent analyst trend is still cautious: JPMorgan raised its price target from $18 to $20 but maintained an Underweight rating on 2026-02-12. That means Wall Street sees limited upside versus the current price. Pros: some analysts see incremental value improvement and operational progress. Cons: the prevailing stance remains bearish, and the target is still far below the current market price. No recent congress trading data was available, and no notable politician or influential figure buying/selling was reported.
